An interventional study of Intervention in Breastfeeding, Skin to Skin Contact and Cesarean Birth, sponsored by Istanbul University - Cerrahpasa. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-02-13.
Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Breast Feeding by Istanbul University - Cerrahpasa — 8 open to participants now, 8 under way, none of them phase 3. Breast Feeding · Istanbul University - Cerrahpasa.
Among the 16 studies in Breast Feeding by Istanbul University - Cerrahpasa, this one is the 12th largest by planned enrollment of the 15 interventional ones that give a count, is one of 6 that started in 2026, is one of 15 with no phase, and was the 12th registered.
1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.
Browse Breast Feeding studies →8 of the 16 studies in Breast Feeding by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–40 · Women only
Istanbul University - Cerrahpasa · Sites in Turkey
Ages up to 30 min · Healthy volunteers
Istanbul University - Cerrahpasa
Women only
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18–40 · Women only
By country, each count listing its studies:
Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2021; this study’s year is marked. 6 started in 2026.
This study's planned enrollment of 60 is below the median of 100 across 846 interventional studies indexed under Breast Feeding.
Median enrollment 100 across the 15 interventional studies, 25 across the 1 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istanbul University - Cerrahpasa is the lead sponsor of 702 studies on the registry; 212 are open to participants now.
4 of the studies in Breast Feeding by Istanbul University - Cerrahpasa that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07890142Istanbul University - CerrahpasaExperiences of Mothers Considering Breastfeeding Cessation: Decision-Making, Method Exploration, and Support Needs | 2027-03 |
| NCT07370051Istanbul University - CerrahpasaEffect of Topical Oxygen and LED Light Therapy on Nipple Crack | 2027-03-15 |
| NCT07867054Istanbul University - CerrahpasaEffects of Maternal and Infant Massage on Breastfeeding and Mother-Infant Bonding | 2027-07-01 |
| NCT07887178Istanbul University - CerrahpasaMethyl Donor-Rich Diet in the Postpartum Period | 2027-10 |
Add all 4 to your calendar (.ics) → With an account.
Among the 16 studies in Breast Feeding by Istanbul University - Cerrahpasa, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled study aims to evaluate the effect of consecutive skin-to-skin contact applied by the mother and father on breastfeeding parameters and parent-infant bonding in babies born by cesarean section. The study includes two groups: an intervention group receiving consecutive skin-to-skin contact by the father followed by the mother, and a control group receiving routine postnatal care. Breastfeeding success and parental bonding will be assessed using validated measurement tools during the early postnatal period and follow-up.
The global increase in cesarean section rates has become a significant public health concern. In Türkiye, the cesarean section rate reached 57.4% in 2023, one of the highest among OECD countries. Babies born by cesarean section are often deprived of early skin-to-skin contact in the immediate postnatal period due to maternal physical limitations, which may negatively affect breastfeeding outcomes and parent-infant bonding.
Skin-to-skin contact and kangaroo care are evidence-based practices known to support neonatal physiological stability, breastfeeding success, pain management, and parent-infant bonding. However, operational and clinical barriers following cesarean delivery often limit the early implementation of maternal skin-to-skin contact. While the effects of skin-to-skin contact have been extensively studied in the context of mother-infant dyads, evidence regarding father-infant skin-to-skin contact remains limited, particularly in term infants.
Delayed maternal contact following cesarean delivery may result in missed opportunities for early bonding and breastfeeding initiation. In this context, involving fathers in early skin-to-skin contact may provide an effective strategy to compensate for delayed maternal contact. Active paternal participation in newborn care has been shown to support infant development, enhance paternal role adaptation, and strengthen family bonding.
This randomized controlled study will be conducted in the delivery and postpartum units of a private mother- and baby-friendly hospital in Istanbul, Türkiye. The study population will consist of mothers and term newborns born by cesarean section who meet the inclusion criteria. Sample size will be determined using G*Power software.
Participants will be randomly assigned to one of two groups. In the intervention group, newborns will receive uninterrupted skin-to-skin contact with the father for 30 minutes immediately after birth. Painful procedures, including hepatitis B vaccination and vitamin K administration, will be performed during father-infant skin-to-skin contact. Following maternal recovery and confirmation of clinical suitability, consecutive skin-to-skin contact will be initiated between the mother and the newborn. The first breastfeeding attempt will occur during maternal skin-to-skin contact.
The control group will receive routine postnatal care according to the hospital's standard protocol.
Breastfeeding success will be assessed using the Bristol Breastfeeding Assessment Tool prior to discharge, on postpartum day 2, and at one month postpartum. Maternal and paternal bonding will be evaluated using the Maternal Postnatal Attachment Scale (MPAS) and the Paternal Postnatal Attachment Scale (PPAS) at the same time points. Breastfeeding parameters and parental bonding outcomes will be statistically compared between the two groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Additional note:
-Eligibility is based on biological sex (female for mothers, male for fathers, newborns of any sex), not on gender identity.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Newborns in this group receive consecutive skin-to-skin contact, first applied by the father for 30 minutes immediately after cesarean delivery, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.
Behavioral: Intervention
Newborns in this group receive routine postpartum and newborn care according to the hospital's standard clinical protocol following cesarean delivery.
Consecutive skin-to-skin contact is applied to newborns born by cesarean section, first by the father for 30 minutes immediately after birth, followed by skin-to-skin contact with the mother as soon as maternal clinical condition allows. Routine newborn care is provided alongside the intervention.
Maternal Postnatal Attachment Scale (MPAS)
Maternal-infant attachment will be measured using the Maternal Postnatal Attachment Scale (MPAS). This 19-item Likert-type self-report scale assesses the mother's emotions and thoughts toward her infant.
Time frame: 3 months
Paternal Postnatal Attachment Scale (PPAS)
Paternal-infant attachment will be measured using the Paternal Postnatal Attachment Scale (PPAS). This 19-item scale evaluates the father's emotional approach, involvement, and interaction with the infant.
Time frame: 3 months
Bristol Breastfeeding Assessment Tool (BBAT)
Breastfeeding success will be assessed using the Bristol Breastfeeding Assessment Tool (BBAT). The tool evaluates mother-infant interaction during breastfeeding, infant positioning, latch, and sucking effectiveness, providing a systematic score of breastfeeding performance.
Time frame: 3 months
Plan to share: No
Start is estimated for Mar 2026; primary completion for Jun 2026, 3 months later.
Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 3 months is below that.
Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul University - Cerrahpasa →